News | August 07, 2024
Sucralose safe to use in small doses; reveals MDRF study
Observes no adverse impact of non-nutritive sweetener (NNS) - sucralose on glycemic markers
Observes no adverse impact of non-nutritive sweetener (NNS) - sucralose on glycemic markers
Revolutionary technology will further boost OneSource’s scientific services offerings
Finerenone significantly reduced the composite of cardiovascular death and total (first and recurrent) heart failure events compared to placebo in addition to usual therapy
Dr. Jitendra Singh’s pioneering work on “Stress Diabetes in Kashmiri Migrants” was hailed by the World Health Organization
The drug will be marketed in different strengths of 150 mg and 440 mg and used in the treatment of patients with HER2
GSK and Flagship to jointly fund up to $150 million upfront
Report highlights significant improvements in adolescent well-being in India
Integrated Disease Surveillance Programme (IDSP) strengthened to improve disease surveillance and rapid data reporting
Campaign launched to spread awareness regarding dengue prevention and control
The partnership will significantly advance their sustainability initiatives by meeting around 67% of their power requirements for these plants
Subscribe To Our Newsletter & Stay Updated
